FUNDAMENTALE HERZ- UND GEFAESSWIRKUNGEN CA⁺⁺-ANTAGONISTISCHER KORONARTHERAPEUTIKA. = THERAPEUTIQUE CORONAIRE FONDAMENTALE ANTAGONISTE DES ACTIONS CARDIOVASCULAIRES DU CA⁺⁺FLECKENSTEIN A.1975; MED. KLIN.; DTSCH.; DA. 1975; VOL. 70; NO 42; PP. 1665-1674; BIBL. 1 P.Article

SPECIFIC PHARMACOLOGY OF CALCIUM IN MYOCARDIUM, CARDIAC PACEMAKERS, AND VASCULAR SMOOTH MUSCLE.FLECKENSTEIN A.1977; ANNU. REV. PHARMACOL. TOXICOL.; U.S.A.; DA. 1977; VOL. 17; PP. 149-166; BIBL. 5 P.Article

Calcium antagonism in heart and vascular smooth muscleFLECKENSTEIN, A.Medicinal research reviews (Print). 1985, Vol 5, Num 4, pp 395-425, issn 0198-6325Article

PHYSIOLOGICAL TONE REGULATION AND DRUG SUSCEPTIBILITY OF CORONARY SMOOTH MUSCULATURE OF EXTRAMURAL STEM ARTERIESFLECKENSTEIN GRUN G; FLECKENSTEIN A.1981; BASIC RES. CARDIOL.; ISSN 0300-8428; DEU; DA. 1981; VOL. 76; NO 5; PP. 550-555; BIBL. 7 REF.Article

FUNDAMENTALE HERZ- UND GEFAESSWIRKUNGEN DES CA⁺⁺-ANTAGONISTISCHEN KORONARTHERAPEUTIKUMS FENDILIN. = LES ACTIVITES CARDIAQUES ET VASCULAIRES FONDAMENTALES DU MEDICAMENT CORONAIRE ANTAGONISTE DU CA⁺⁺ FENDILINEFLECKENSTEIN A; FLECKENSTEIN GRUEN G; BYON YK et al.1977; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1977; VOL. 27; NO 3; PP. 562-571; ABS. ANGL.; BIBL. 1/2 P.Article

ZUM MECHANISMUS DER KARDIOPROTEKTIVEN WIRKUNG VON TRIAMTEREN AN RATTENHERZEN. MYOKARDSCHUTZ DURCH STEIGERUNG DER EXTRAZELLULAEREN K⁺- UNF MG⁺⁺-KONZENTRATIONEN. = LE MECANISME DE L'ACTION CARDIOPROTECTRICE DU TRIAMTERENE SUR LE COEUR DU RAT. PROTECTION DU MYOCARDE PAR L'ACCROISSEMENT DES CONCENTRATIONS EXTRACELLULAIRES DE K⁺ ET DE MG⁺⁺FLECKENSTEIN A; JANKE J; FREY M et al.1977; ARZENEIMITTEL-FORSCH.; DTSCH.; DA. 1977; VOL. 27; NO 2; PP. 382-389; ABS. ANGL.; BIBL. 1 P.Article

VERGLEICHENDE UNTERSUCHUNGEN UEBER DIE CA++ ANTAGONISTISCHEN GRUNDWIRKUNGEN VON NILUDIPIN (BAY A 7168) UND NIFEDEPIN (BAY A 1040) AUF MYOKARD, MYOMETRIUM UND GLATTE GEFAESSMUSKULATUR = RECHERCHES COMPAREES SUR LES ACTIVITES FONDAMENTALES ANTAGONISTES DU CA⁺⁺ DE LA NILUDIPINE (BAY A 7168) ET DE LA NIFEDIPINE (BAY A 1040) SUR LE MYOCARDE, LE MYOMETRE ET LA MUSCULATURE VASCULAIRE LISSEFLECKENSTEIN A; FLECKENSTEIN GRUEN G; BYON YK et al.1979; ARZNEIMITTEL-FORSCH.; DEU; DA. 1979; VOL. 29; NO 2; PP. 230-246; ABS. ENG; BIBL. 2 P.Article

EINSCHRAENKUNG DER ISOPROTERENOL-INDUZIERTEN ⁴⁵CA⁺⁺-NETTO-AUFNAHME UND DER UTILISATION VON ENERGIEREICHEM PHOSPHAT IM HYPERTROPHIERTEN RATTENMYOKARD = REDUCTION DE LA FIXATION DE ⁴⁵CA⁺⁺ INDUITE PAR ISOPROTERENOL ET DE L'UTILISATION DU PHOSPHATE RICHE EN ENERGIE DANS LE MYOCARDE HYPERTROPHIE DU RATHEIN B; FLECKENSTEIN A; JANKE J et al.1972; VERH. DTSCH. GESELLSCH. KREISLAUFFORSCH.; DTSCH.; DA. 1972; VOL. 38; PP. 196-201; BIBL. 1/2 P.Serial Issue

Calcium antagonists into the nineties: appraisal and future trends, verapamil satellite symposium: 25th. Anniversary symposium on calcium antagonists, Basel, February 12, 1988FLECKENSTEIN, A; O'MALLEY, K.Journal of cardiovascular pharmacology. 1989, Vol 13, issn 0160-2446, 82 p., suppl. 4Conference Proceedings

Drugs looking for diseases: innovative drug research and the development of the beta blockers and the calcium antagonistsVOS, Rein; FLECKENSTEIN, A.Developments in cardiovascular medicine. 1991, Vol 120, issn 0166-9842, 403 p.Serial Issue

DIFFERENTIATION OF THE TRANSMEMBRANE NA AND CA CHANNELS IN MAMMALIAN CARDIAC FIBRES BY THE USE OF SPECIFIC INHIBITORS = DIFFERENTIATION DES VOIES TRANSMEMBRANAIRES DE NA ET DE CA DANS LES FIBRES CARDIAQUES DES MAMMIFERES AU MOYEN D'INHIBITEURS SPECIFIQUESKOHLHARDT M; BAUER B; KRAUSE H et al.1972; PFLUEGERS ARCH.; DTSCH.; DA. 1972; VOL. 335; NO 4; PP. 309-322; BIBL. 1P.1/2Serial Issue

DIFFERENZIERUNG ZWISCHEN DEN BETA -ADRENOLYTISCHEN UND CA⁺⁺-ANTAGONISTISCHEN WIRKUNGSKOMPONENTEN VON BETA -RECEPTORENBLOCKERN AM MYOKARD UND AN GLATTER MUSKULATUR UNTER BESONDERER BERUECKSICHTIGUNG VON TRASICAR = DIFFERENCIATION ENTRE LES COMPOSANTES D'ACTION BETA -ADRENOLYTIQUES ET CA⁺⁺-ANTAGONISTES, DE BLOQUANTS DES BETA -RECEPTEURS SUR LE MYOCARDE ET LA MUSCULATURE LISSE, PARTICULIEREMENT DANS LE CAS DU TRASICORGRUEN G; BYON KY; KAUFMANN R et al.1972; AERZTL. FORSCH.; DTSCH.; DA. 1972; VOL. 26; NO 11; PP. 369-378; ABS. ANGL.; BIBL. 12REF.Serial Issue

Prevention of cerebrovascular spasms with nimodipineFLECKENSTEIN-GRUÊN, G; FLECKENSTEIN, A.Stroke (1970). 1990, Vol 21, Num 12, pp IV64-IV71, issn 0039-2499, SUPConference Paper

Differential effects of histamine on the activity of hypothalamic dopaminergic neurons in the ratFLECKENSTEIN, A. E; LOOKINGLAND, K. J; MOORE, K. E et al.The Journal of pharmacology and experimental therapeutics. 1994, Vol 268, Num 1, pp 270-276, issn 0022-3565Article

Differential role of histamine in mediating stress-induced changes in central dopaminergic neuronal activity in the ratFLECKENSTEIN, A. E; LOOKINGLAND, K. J; MOORE, K. E et al.Brain research. 1994, Vol 653, Num 1-2, pp 267-272, issn 0006-8993Article

Experimental antiarteriosclerotic effects of calcium antagonistsFLECKENSTEIN, A; FLECKENSTEIN-GRÜN, G; FREY, M et al.Journal of clinical pharmacology. 1990, Vol 30, Num 2, pp 151-154, issn 0091-2700, 4 p.Article

Differential regional effects of methamphetamine on the activities of tryptophan and tyrosine hydroxylaseHAUGHEY, H. M; FLECKENSTEIN, A. E; HANSON, G. R et al.Journal of neurochemistry. 1999, Vol 72, Num 2, pp 661-668, issn 0022-3042Article

Histaminergic neurons mediate restraint stress-induced activation of central 5-hydroxytryptaminergic neurons in the ratFLECKENSTEIN, A. E; LOOKINGLAND, K. J; MOORE, K. E et al.European journal of pharmacology. 1994, Vol 264, Num 2, pp 163-167, issn 0014-2999Article

Evidence that histamine-stimulated prolactin secretion is not mediated by an inhibition of tuberoinfundibular dopaminergic neuronsFLECKENSTEIN, A. E; LOOKINGLAND, K. J; MOORE, K. E et al.Life sciences (1973). 1992, Vol 51, Num 10, pp 741-746, issn 0024-3205Article

Activation of noradrenergic neurons projecting to the diencephalon following central administration of histamine is mediated by H₁ receptorsFLECKENSTEIN, A. E; LOOKINGLAND, K. J; MOORE, K. E et al.Brain research. 1994, Vol 638, Num 1-2, pp 243-247, issn 0006-8993Article

Histaminergic neurons mediate restraint stress-induced increases in the activity of noradrenergic neurons projecting to the hypothalamusFLECKENSTEIN, A. E; LOOKINGLAND, K. J; MOORE, K. E et al.Brain research. 1994, Vol 653, Num 1-2, pp 273-277, issn 0006-8993Article

Activation of mesolimbic dopaminergic neurons following central administration of histamine is mediated by H₁ receptorsFLECKENSTEIN, A. E; LOOKINGLAND, K. J; MOORE, K. E et al.Naunyn-Schmiedeberg's archives of pharmacology. 1993, Vol 347, Num 1, pp 50-54, issn 0028-1298Article

Protective effects of various calcium antagonists against experimental arteriosclerosisFLECKENSTEIN-GRÜN, G; FREY, M; THIMM, F et al.Journal of human hypertension. 1992, Vol 6, pp S13-S18, issn 0950-9240, SUP1Conference Paper

3,4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter functionMETZGER, R. R; HANSON, G. R; GIBB, J. W et al.European journal of pharmacology. 1998, Vol 349, Num 2-3, pp 205-210, issn 0014-2999Article

Oxygen radicals differentially affect Na⁺/Cl^--dependent transportersHAUGHEY, H. M; BROWN, J. M; FLECKENSTEIN, A. E et al.European journal of pharmacology. 1999, Vol 379, Num 1, pp 107-110, issn 0014-2999Article